In a controversial move, former US President Donald Trump has halted funding disbursements under the President’s Emergency Plan for AIDS Relief (PEPFAR) for at least 90 days.
.jpeg)
The programme, which has been a lifeline for HIV/AIDS treatment in Nigeria and other developing countries, was launched in 2003 by President George W. Bush to combat the spread of HIV/AIDS globally.
The suspension affects all US government agencies managing foreign development assistance programmes, with Trump’s administration citing the need for a review of how PEPFAR funds are being utilized.
The review, according to the administration, aims to ensure that the funds are being effectively used and to address concerns over potential misuse in some countries.
PEPFAR has been instrumental in saving millions of lives, particularly in Africa, where the HIV/AIDS epidemic remains a significant challenge.
Its support has provided antiretroviral therapy, prevention services, and care for affected individuals and communities.
The decision has sparked widespread concern among health advocates and recipient countries, including Nigeria, which heavily relies on PEPFAR funding to sustain its HIV/AIDS programmes.
Critics argue that the suspension could disrupt critical treatment efforts, putting millions of lives at risk and reversing progress made in combating the virus.
Trump’s administration defended the decision, emphasizing the importance of accountability and efficiency in US foreign aid programmes.
However, stakeholders are urging the US government to expedite the review process to avoid prolonged disruptions to life-saving treatments.
The suspension has left healthcare professionals and beneficiaries anxiously awaiting clarity on the future of the programme and its impact on vulnerable populations.